Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study

Simple item page
dc.contributor.authorAtukunda, Esther Cathyln
dc.contributor.authorBrhlikova, Petra
dc.contributor.authorAgaba, Amon Ganafa
dc.contributor.authorPollock, Allyson M
dc.date.accessioned2022-08-08T08:23:21Z
dc.date.available2022-08-08T08:23:21Z
dc.date.issued2013
dc.description.abstractBackground: Poor access to essential medicines remains a barrier to improvement of health in low-income countries. The maternal mortality rate from post-partum haemorrhage (PPH) in Uganda is one of the highest in the world. Uganda launched a misoprostol rollout programme for prevention of PPH in 2009, before WHO added it to the Essential Medicines List. We assessed the rollout programme in Uganda.en_US
dc.description.sponsorshipEuropean Unionen_US
dc.identifier.citationAtukunda, E. C., Brhlikova, P., Agaba, A. G., & Pollock, A. M. (2013). Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet, 382, 10.en_US
dc.identifier.urihttp://ir.must.ac.ug/handle/123456789/2344
dc.language.isoen_USen_US
dc.publisherThe Lanceten_US
dc.subjectRegistrationen_US
dc.subjectProcurementen_US
dc.subjectDistributionen_US
dc.subjectUse of misoprostolen_US
dc.subjectUgandaen_US
dc.titleRegistration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational studyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Registration, procurement, distribution, and use of misoprostol in Uganda- an interview-based observational study.pdf
Size:
49.96 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles